SOX9 and prostate carcinoma: While there exists no detectable expression in lumina epithelial cells, SOX9 has already been reported as “expressed in primary prostate cancer in vivo, at a higher frequency in recurrent prostate cancer and in prostate cancer cell lines (LNCaP, CWR22, PC3, and DU145)” [80].